Replies to post #175775 on Biotech Values

[exwannabe]

Not if it is priced 20-30% higher if you ask me or majority payers.

I am far from convinced they will price that aggressively (that low). In much of the population they can compete straight up.

Nobody starts a price war when there are only 2 players.